Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Positive    source : Neurosense.investorroom.com    save search

NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting
Published: 2024-04-18 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | News | $1.33 -2.21% -2.26% 130K twitter stocktwits trandingview |
| | O: -0.63% H: 1.89% C: -4.4%

neurology presentation readout positive topline meeting
NeuroSense Reports Additional Positive Results from its ALS Phase 2b PARADIGM Trial
Published: 2024-02-21 (Crawled : 13:30) - neurosense.investorroom.com
NRSN | News | $1.33 -2.21% -2.26% 130K twitter stocktwits trandingview |
| | O: -3.65% H: 0.0% C: -5.3%

als positive trial results
NeuroSense Therapeutics Reports Positive Preliminary Results in Parkinson's Biomarker Study
Published: 2023-05-02 (Crawled : 12:20) - neurosense.investorroom.com
NRSN | News | $1.33 -2.21% -2.26% 130K twitter stocktwits trandingview |
| | O: 0.0% H: 2.87% C: -20.1%

parkinson's biomarker positive therapeutics results study
NeuroSense Therapeutics Reports Positive Final Results from Alzheimer's Biomarker Study
Published: 2023-01-19 (Crawled : 14:00) - neurosense.investorroom.com
NRSN | News | $1.33 -2.21% -2.26% 130K twitter stocktwits trandingview |
| | O: 69.84% H: 35.98% C: 3.74%

alzheimer's biomarker therapeutics positive results study
NeuroSense Announces Positive PrimeC Pharmacokinetic Study Results & Anticipates Phase IIb ALS Enrollment to Expand into the US
Published: 2022-09-28 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | News | $1.33 -2.21% -2.26% 130K twitter stocktwits trandingview |
| | O: 10.18% H: 6.26% C: -2.17%

primec als positive results study
NeuroSense Therapeutics Reports Positive Preliminary Results from Novel Alzheimer's Biomarker Study
Published: 2022-06-30 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | News | $1.33 -2.21% -2.26% 130K twitter stocktwits trandingview |
| | O: 45.26% H: 12.31% C: -15.08%

alzheimer's therapeutics positive results tdp-43 biomarkers
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.